A detailed history of Susquehanna International Group, LLP transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 45,878 shares of TERN stock, worth $268,845. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,878
Previous 35,830 28.04%
Holding current value
$268,845
Previous $244,000 56.56%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.49 - $10.8 $65,211 - $108,518
10,048 Added 28.04%
45,878 $382,000
Q2 2024

Aug 15, 2024

BUY
$4.54 - $8.2 $73,034 - $131,913
16,087 Added 81.48%
35,830 $244,000
Q1 2024

May 07, 2024

SELL
$4.86 - $8.19 $207,526 - $349,721
-42,701 Reduced 68.38%
19,743 $129,000
Q4 2023

Feb 14, 2024

BUY
$3.37 - $6.86 $78,649 - $160,098
23,338 Added 59.68%
62,444 $405,000
Q3 2023

Nov 14, 2023

SELL
$4.7 - $8.55 $591,001 - $1.08 Million
-125,745 Reduced 76.28%
39,106 $196,000
Q2 2023

Aug 11, 2023

SELL
$7.35 - $13.29 $1.2 Million - $2.17 Million
-163,177 Reduced 49.74%
164,851 $1.44 Million
Q1 2023

May 16, 2023

BUY
$7.91 - $12.0 $2.29 Million - $3.48 Million
289,926 Added 760.92%
328,028 $3.88 Million
Q4 2022

Feb 14, 2023

BUY
$4.62 - $10.18 $176,031 - $387,878
38,102 New
38,102 $387,000

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $220M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.